Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Anti-VEGF vs Dexamethasone Implant for DME
NCT03999125Phase 4Unknown
- Sponsor
- Sudhalkar Eye Hospital
- Start
- Jun 2019
- Primary completion
- Jun 2021
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
Phase 4, randomised, single-blind trial of dexamethasone in diabetic macular edema (DME) (3 arms), sponsored by Sudhalkar Eye Hospital. Primary endpoint: Best Corrected Visual Acuity at 2 years. Status: unknown.
02
Drugs
dexamethasone
03
Conditions
diabetic macular edema (DME)
Beyond the preview
Go deeper on NCT03999125.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03999125.